In the light of the rapid and recent falls from grace of companies such as British Biotech (Oxford, UK) and Cortecs (Isleworth, UK), the UK trade organization the BioIndustry Association proposed a code of conduct on July 8 that urges companies to seek external advice both on matters that have to be disclosed to shareholders and on scientific/clinical affairs. BIA plans to "name and shame" transgressors and, if necessary, revoke their membership of the association (Nature Biotechnol., 17, 12).